Skip to main navigation Skip to search Skip to main content

Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation

  • Daniela Schuster
  • , Patrick Markt
  • , Ulrike Grienke
  • , Judit Mihaly-Bison
  • , Markus Binder
  • , Stefan M. Noha
  • , Judith M. Rollinger
  • , Hermann Stuppner
  • , Valery N. Bochkov
  • , Gerhard Wolber

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)7168-7180
Number of pages13
JournalBioorganic & Medicinal Chemistry
Volume19
Issue number23
DOIs
Publication statusPublished - 1 Dec 2011
Externally publishedYes

Funding

This work was funded by the NFN-project 'Drugs from Nature Targeting Inflammation - DNTI', Subprojects-No. S10702/10711, S10703, and S10709/10713 from the Austrian Science Fund (FWF). D.S. is grateful for a young talents grant and the Erika Cremer Habilitations Program from the University of Innsbruck. We thank the National Cancer Institute for providing the FXR test compounds free of charge.

Austrian Fields of Science 2012

  • 104013 Natural product chemistry

Keywords

  • Farnesoid X receptor
  • Molecular modeling
  • Virtual screening
  • Lead identification
  • FXR agonist
  • FARNESOID-X-RECEPTOR
  • BILE-ACID RECEPTOR
  • NUCLEAR RECEPTOR
  • DRUG DISCOVERY
  • POTENT
  • IDENTIFICATION
  • ANTAGONIST
  • ACTIVATION
  • DATABASE
  • ANALOGS

Cite this